Sức Khỏe

China tests vaccine against Omicron . variant

China is testing a vaccine against the Omicron variant - Photo 1.

Artwork: REUTERS

China’s Suzhou Abogen Biosciences biotechnology company announced on April 30 that a potential COVID-19 vaccine developed by this company and its partner Walvax Biotechnology based on mRNA technology has been approved for testing. clinical practice in the United Arab Emirates (UAE).

Currently, Abogen, pharmaceutical companies Pfizer/BioNTech (of the US and Germany) and Moderna (the US) are “racing” in an effort to test specific potential vaccines to prevent Omicron – a variant of the virus. SARS-CoV-2 is considered by scientists to be highly infectious and “dodges” the antibodies produced by available vaccines.

According to Abogen, in addition to the UAE, the company has also contacted regulatory authorities in China and a number of other countries about clinical trials of vaccines against Omicron and its subtypes.

The mRNA vaccine, co-developed by Abogen with Walvax Biotechnology and backed by a Chinese military-backed research organization, is also undergoing phase 3 trials in China, Mexico and Indonesia.

In addition, Walvax Biotechnology is also working with Shanghai-based startup RNACure to develop another potential mRNA vaccine – which also targets the Omicron variant, but also targets the Omicron variant. has a different formulation than the one in cooperation with Abogen.

Previously, two specific vaccines against Omicron of Sinopharm and Sinovac – which are inactivated or virus-killing vaccines – were clinically tested in the Hong Kong special administrative region (China) and mainland China. green. The UAE has also approved clinical trials for these two specifically inactivated vaccines.

Up to now, mainland China has vaccinated more than 88% of the country’s 1.4 billion people eligible to be vaccinated against COVID-19 with non-mRNA-based vaccines.

China has not approved the use of any vaccines manufactured by other countries, even though actual data shows that the two most used Chinese-made products – those of Sinopharm and Sinovac – are effective. The effectiveness of preventing COVID-19 was lower than that of the two mRNA vaccines of Pfizer/BioNTech and Moderna.

The BA.4, BA.5 variants of Omicron have not been recorded in Vietnam yet The BA.4, BA.5 variants of Omicron have not been recorded in Vietnam yet

TTO – Immediately after the World Health Organization (WHO) announced the monitoring of a number of infections with two new sub-variants of the Omicron variant, BA.4 and BA.5, discussed with Tuoi Tre Online, a representative of the Department Preventive medicine said that Vietnam has not yet recorded this variant.

You are reading the article China tests vaccine against Omicron . variant
at Blogtuan.info – Source: tuoitre.vn – Read the original article here

Back to top button